Imagine receiving a Stage IV lung cancer diagnosis after mistaking the initial symptoms for simple back pain and a cough. That's exactly what happened to Kevin Humphrey, an otherwise healthy and athletic young father. His story is a powerful testament to resilience, the importance of seeking second opinions, and the advancements in targeted cancer therapies.
This article, originally reported by Kerry Breen, a news editor at CBSNews.com with a background in covering current events and health issues, delves into Kevin's journey. Breen, a graduate of New York University's Arthur L. Carter School of Journalism, previously worked at NBC News' TODAY Digital.
Kevin, an endurance athlete accustomed to pushing his body to its limits through ultramarathons, first noticed persistent back pain in January 2024. He also developed a cough. Initially diagnosed with pneumonia, his symptoms lingered even after treatment. When a chest CT scan revealed "something going on" in his left lung, the quest for answers began. A biopsy proved inconclusive, but Kevin's intuition told him something was seriously wrong.
Driven by this feeling, Kevin sought a second opinion at Northwestern Medicine in Chicago in May 2024. A bronchoscopy revealed the shocking truth: a tumor was crushing the left side of his windpipe, explaining his cough and pain. The diagnosis? Stage IV non-small cell adenocarcinoma, a type of lung cancer.
"I was really in disbelief," Kevin recalled, emphasizing that he had never smoked and had no family history of the disease. "It wasn't even on my radar as a possibility."
Kevin's case highlights a concerning trend: the increasing number of lung cancer diagnoses in young, non-smoking individuals. Dr. Jonathan Villena-Vargas, a thoracic surgeon at NewYork-Presbyterian and Weill Cornell Medicine, has noted that environmental or lifestyle factors might be contributing to this rise. But here's where it gets controversial... the exact causes remain unclear, sparking ongoing research and debate within the medical community. What do you think about this? Are environmental factors being adequately addressed, or is there a need for more in-depth investigation?
Further tests revealed the cancer had spread beyond Kevin's lung and had likely been growing for at least a year. At this stage, the disease typically has a 37% 5-year survival rate. However, Dr. Daniel Dammrich, Kevin's oncologist at Northwestern Medicine, identified a "driver mutation" fueling the cancer's growth. These mutations, more common in young, non-smoking patients, proved to be a crucial turning point.
Identifying the mutation "really opened the door for some of our more nuanced, targeted therapies," Dr. Dammrich explained, transforming what was initially a "very concerning and dire situation into a much more optimistic one." This emphasizes the importance of personalized medicine and genetic testing in cancer treatment.
Kevin and Dr. Dammrich devised an aggressive treatment plan combining targeted immunotherapy with chemotherapy, aiming to shrink the tumor enough for surgical removal. Following immunotherapy and chemotherapy throughout the summer of 2024, the tumor became operable by August.
The surgery involved removing about half of Kevin's left lung. And this is the part most people miss... the mental and emotional toll such a procedure can take, especially on an athlete. Kevin wondered if he would ever be able to run, bike, or participate in endurance sports again. "That was the biggest question mark going into surgery," he admitted.
Despite his fears, Kevin set a goal: to compete in the Michigan Ironman 70.3 race, scheduled a year and a day after his surgery. This included a 1-mile swim, a 56.1-mile bike ride, and a 13.2-mile run.
Following surgery in mid-September, recovery was arduous. Broken ribs and a large incision made even simple tasks challenging. Running was impossible for months. But Kevin persevered, driven by his goal.
On September 14th, Kevin joined over 1,600 athletes in the Ironman. He finished in under five and a half hours, placing 411th. The race was an emotional experience, a culmination of his journey.
"You're replaying everything that's happened over the past year and the whirlwind it's been," Kevin said. "For me, when I got to the point of knowing 'I'm going to finish this race' and thinking about my young boys, my wife, the family and the community and support system we've had throughout the whole year, and how grateful I am to not only be here but to continue to do these types of races and events. I certainly did not think that was going to be the case when I received the diagnosis in May of '24."
Currently, Kevin shows no evidence of disease, a complete response to the treatment. He continues immunotherapy with minimal side effects and undergoes regular monitoring.
Adding another incredible feat to his journey, Kevin ran the Chicago Marathon on October 12th, less than a month after the Ironman. He finished in about seven and a half hours, slower than his previous time, but finishing was the victory.
"My goal was just to get across the finish line, and that's what we did," Kevin said. "I was just grateful for the ability to be out there and to run and be doing the things that I've loved doing for such a long time."
Kevin's story is a powerful reminder that even in the face of a Stage IV cancer diagnosis, hope, determination, and advancements in medical treatments can lead to remarkable outcomes. It also underscores the importance of listening to your body and advocating for your health. What part of Kevin's story resonated with you the most? Do you think his positive attitude played a significant role in his recovery? Share your thoughts in the comments below!
